Share your thoughts on our News & Insights section. Complete our survey to help us improve.

Share research

Fevertree: first-half sales fall short of expectations

Fevertree’s had a tough start to the year, and full-year sales targets have been wound back as a result.
Fevertree - US market fuels sales growth

No recommendation - No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.

Prices delayed by at least 15 minutes

Fevertree’s first-half revenue was broadly flat at £172.9mn ignoring currency impacts, which fell short of market expectations.

Double-digit revenue growth in the US and the Rest of the World was offset by declines in the UK and Europe, where unfavourable weather in the second quarter and the timing of shipments weighed on performance. Despite this, Fevertree gained market share across all regions.

Underlying operating profit rose from £0.6mn to £12.2mn as shipping rates, energy costs, and wider inflationary pressures eased.

Free cash flow improved from an outflow of £7.3mn to an inflow of £22.1mn. Net cash, including lease liabilities, was £59.7mn at the half-year mark.

Markets are now expecting full-year revenue to grow by 2-3%, down from the 8% growth management guided to at start of the year.

An interim dividend of 5.85p per share was announced, up 2%.

The shares fell 6.7% following the announcement.

Our view

Fevertree’s first-half sales fell short of market expectations, causing the valuation to take a hit on the day. Despite the shortfall, Fevertree did manage to gain market share across all the regions it operates in.

US growth looks especially healthy, and despite already being the group's largest region by sales, we think there's a lot further to go, given the vast size of this market.

Fevertree continues to expand its drinks portfolio with new products, and non-tonic mixers have grown to around 42% of total sales. These new offerings open the door to different types of drinkers, drastically increasing the number of customers it has to go after. We see a long runway for sales growth if it can execute well here.

To help make consumers aware of these new offerings, Fevertree’s not held back on advertising. Marketing spend in the first half was almost 10% of total sales, and there’s little sign of the group letting up on this front.

Profitability has improved, mainly through price increases and lower glass and shipping costs. Prices on many of its energy contracts for next year have been locked in too, meaning there should be no nasty surprises in the near term. The focus now shifts to ramping up production and improving efficiencies to help keep margins moving in the right direction.

But there are some challenges to be wary of.

UK sales continue to trend in the wrong direction. It turns out there is a cap on how much premium tonic you can sell, and it looks like Fevertree has reached it in its home market. Successful international expansion will be critical to continued growth.

The economic backdrop is looking a touch brighter than it did a year ago. But consumers' budgets remain stretched, so any unexpected shocks could see consumers trade down to cheaper alternatives if future price hikes aren't managed delicately.

The balance sheet is in good shape thanks to low debt levels, and there’s currently a prospective 2.1% dividend yield on offer. Given the amount of cash on the balance sheet, management has hinted that increased shareholder returns are on the cards in the new year. More details will come alongside full-year results, but a special dividend is the most likely option in our eyes. As always, no shareholder returns are guaranteed.

We're pleased to see momentum has turned positive. But despite the recent decline, the valuation still looks quite high to us. We'd like to see continued signs that overseas expansion is boosting the bottom line before we get excited about this mixer maker.

Environmental, social and governance (ESG) risk

The food and beverage industry tends to be medium-risk in terms of ESG though some segments like agriculture, tobacco and spirits fall into the high-risk category. Product governance is a key risk industry-wide, especially in areas with strict quality and safety requirements. Labour relations and supply chain management are also industry-wide risks, with other issues varying by sub-sector.

According to Sustainalytics, Fevertree’s management of ESG risk is average.

The group doesn’t use plastic bottles but instead uses glass or cans from a portion of recycled materials. As such, the group’s products are completely recyclable, however, they are energy-intensive to mould and make. Fevertree also claims its range of mixers sold in the UK are carbon neutral. However, no concrete scope emission reduction targets appear to be in place.

Fevertree key facts

All ratios are sourced from Refinitiv, based on previous day’s closing values. Please remember yields are variable and not a reliable indicator of future income. Keep in mind key figures shouldn’t be looked at on their own – it’s important to understand the big picture.

This article is original Hargreaves Lansdown content, published by Hargreaves Lansdown. It was correct as at the date of publication, and our views may have changed since then. Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment.No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment.This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication.Non - independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place(including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing.Please see our full non - independent research disclosure for more information.
Latest from Share research
Weekly Newsletter
Sign up for Share Insight. Get our Share research team’s key takeaways from the week’s news and articles direct to your inbox every Friday.
Written by
Aarin Chiekrie
Aarin Chiekrie
Equity Analyst

Aarin is a member of the Equity Research team. Alongside our other analysts, he provides regular research and analysis on individual companies and wider sectors. Having a keen interest in global economics, he knows how macro-events can impact individual companies.

Our content review process
The aim of Hargreaves Lansdown's financial content review process is to ensure accuracy, clarity, and comprehensiveness of all published materials
Article history
Published: 12th September 2024